Midwest Corporate Access Day
- 9/26/2018
Both days featured 1 on 1 meetings with a select group of companies focused on specialty pharma and orphan and rare disease. Investors had the opportunity to meet with management teams to discuss in detail key therapeutic programs in development and recent corporate updates.